Aviva (GU80) AI Stock Analysis

Aviva

(Frankfurt:GU80)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Wealth growthStrong net flows, rising assets and profit growth support recurring fee income and deepen Aviva’s position in savings and retirement. Continued customer and AUM expansion can improve operating leverage and diversify earnings beyond insurance underwriting.

Negative Factors

Unstable cash conversionRepeatedly uneven cash generation reduces visibility into earnings quality and limits confidence in internally funded growth. Reserve movements, working-capital timing and insurance liability flows can continue to make reported profitability less predictable.

Aviva (GU80) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 29.36B
Dividend Yield: 5.43%
Average Volume (3M): 169
Price to Earnings (P/E): 40.3
Beta (1Y): 0.63
Revenue Growth: 79.96%
EPS Growth: -19.92%
Country: Germany
Employees: 39,359
Sector: Financial
Sector Strength: 68
Industry: Insurance - Diversified

Aviva Business Overview & Revenue Model

Company Description

Aviva plc provides various insurance, retirement, and wealth products in the United Kingdom, Ireland, Canada, India, and China. It operates through General Insurance; Insurance, Wealth & Retirement; Aviva Investors; and International Investments segm...

Aviva Earnings Call Summary

Earnings Call Date:Aug 13, 2026(Q2-2026)|% Change Since:6.84%|Next Earnings Date:Mar 03, 2027

Earnings Call SentimentPositive

The call portrayed a firmly positive operational and financial momentum—notably strong growth in operating profit (24%), EPS (10%), Wealth net flows (+32%), cash remittances (+47%) and clear progress on Direct Line integration and AI initiatives—while acknowledging manageable headwinds: Protection profit decline, Health falling short of its GBP 100m target, recent Canada CAT/weather risk and some underlying GI margin impacts from large losses and one‑off items. Management emphasizes balance‑sheet strength (176% solvency, aiming high‑180s), delivery of synergies and disciplined capital‑light progression, presenting more positives than negatives overall.

Positive Updates

Strong overall financial performance

Operating profit rose 24% to GBP 1.3bn; operating EPS grew ~10%; IFRS return on equity was above 20% (20.3% reported). Cash remittances increased 47% to GBP 1.5bn.

Negative Updates

Protection profitability deterioration

Protection operating profit fell ~14% in the half, driven by adverse experience variances and investment in the business despite sales rising only ~1%.

Company Guidance

The call guided to continued strong delivery: H1 operating profit rose 24% to £1.3bn with operating EPS up 10% and IFRS ROE at 20.3%, and the board declared an interim dividend of 14p (up 7%) after completing the latest buyback; cash remittances were up 47% to £1.5bn and underlying operating capital generation rose 14% to £812m. Solvency was 176% at half‑year (after a 9‑point operating capital generation add and c.3 points of non‑operating items) and management expects the ratio to be in the high‑180s by year‑end (including at least 7 additional points / £350m of Direct Line capital synergies); group full‑year operating EPS is guided to be around 11%. Key business guidance includes GI momentum with a headline COR improved to ~93.3–93.4% (on track for 2026 guidance) and Direct Line cost synergies of £130m this year (£100m run‑rate delivered so far, plus £150m capital synergies and £40m annual claims savings); Wealth net flows were up 32% to £7.6bn (AUM >£260bn) and management remains on track for £280m Wealth operating profit by 2027; Health now expects c.£90m operating profit in 2026; Retirement BPA IRR was 18% (BPA £1.1bn, YTD volumes £1.9bn).

Aviva Risk Analysis

Aviva disclosed 15 risk factors in its most recent earnings report. Aviva reported the most risks in the "Macro & Political" category.

Macro & Political - Risks related to catastrophic events or geopolitical conditions that may disrupt the company’s business

Latest Risks Added

2 New Risks

1.Longevity advancements (e.g. due to medical advances)Q4, 2021

2.TalentQ4, 2021

Aviva Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

DE:GU80 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACGL	83Outperform	$36.29B	8.59	18.35%	―	-5.29%	14.08%
HIG	82Outperform	$35.46B	7.95	24.13%	1.81%	4.08%	34.70%
BRK.B	77Outperform	$1.16T	13.67	11.86%	―	3.93%	36.30%
AEG	74Outperform	$12.41B	11.38	12.23%	5.93%	24.97%	―
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
AIG	65Neutral	$42.82B	14.86	7.27%	2.32%	-4.19%	1.09%

* Financial Sector Average

Performance Comparison

DE:GU80 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:GU80	Aviva Plc Sponsored Adr	16.80	2.67	18.88%
AEG	Aegon Nv	8.18	0.96	13.25%
AIG	American International Group, Inc.	81.90	4.84	6.28%
ACGL	Arch Capital	106.36	20.36	23.67%
HIG	Hartford Insurance Group Inc	132.59	10.51	8.61%
BRK.B	Berkshire Hathaway B	542.49	66.81	14.05%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Aviva AI Stock Analysis